Logo image of JBLU

JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

USA - NASDAQ:JBLU - US4771431016 - Common Stock

4.72 USD
+0.15 (+3.28%)
Last: 10/27/2025, 8:00:03 PM
4.81 USD
+0.09 (+1.91%)
Pre-Market: 10/28/2025, 6:44:33 AM
Fundamental Rating

2

Taking everything into account, JBLU scores 2 out of 10 in our fundamental rating. JBLU was compared to 21 industry peers in the Passenger Airlines industry. JBLU has a bad profitability rating. Also its financial health evaluation is rather negative. JBLU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JBLU had negative earnings in the past year.
JBLU had a negative operating cash flow in the past year.
In the past 5 years JBLU always reported negative net income.
JBLU had a positive operating cash flow in 4 of the past 5 years.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.28%, JBLU is in line with its industry, outperforming 42.86% of the companies in the same industry.
With a Return On Equity value of -16.03%, JBLU perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
ROA -2.28%
ROE -16.03%
ROIC N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

JBLU has a Gross Margin of 69.00%. This is amongst the best in the industry. JBLU outperforms 85.71% of its industry peers.
JBLU's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for JBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
JBLU has more shares outstanding than it did 1 year ago.
The number of shares outstanding for JBLU has been increased compared to 5 years ago.
The debt/assets ratio for JBLU is higher compared to a year ago.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.63, we must say that JBLU is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.63, JBLU is in line with its industry, outperforming 47.62% of the companies in the same industry.
JBLU has a Debt/Equity ratio of 3.21. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.21, JBLU perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.21
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC5.39%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

JBLU has a Current Ratio of 0.88. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
JBLU's Current ratio of 0.88 is amongst the best of the industry. JBLU outperforms 85.71% of its industry peers.
JBLU has a Quick Ratio of 0.88. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
JBLU's Quick ratio of 0.84 is amongst the best of the industry. JBLU outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.84
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

JBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.43%.
Looking at the last year, JBLU shows a decrease in Revenue. The Revenue has decreased by -1.90% in the last year.
Measured over the past years, JBLU shows a small growth in Revenue. The Revenue has been growing by 2.77% on average per year.
EPS 1Y (TTM)-20.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-1.9%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.97%

3.2 Future

Based on estimates for the next years, JBLU will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.71% on average per year.
Based on estimates for the next years, JBLU will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y-125.95%
EPS Next 2Y-16.26%
EPS Next 3Y19.71%
EPS Next 5YN/A
Revenue Next Year-2.19%
Revenue Next 2Y2.2%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

0

4. Valuation

4.1 Price/Earnings Ratio

JBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBLU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

61.90% of the companies in the same industry are cheaper than JBLU, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.56
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

JBLU's earnings are expected to grow with 19.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.26%
EPS Next 3Y19.71%

0

5. Dividend

5.1 Amount

No dividends for JBLU!.
Industry RankSector Rank
Dividend Yield N/A

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (10/27/2025, 8:00:03 PM)

Premarket: 4.81 +0.09 (+1.91%)

4.72

+0.15 (+3.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners77.33%
Inst Owner Change0.05%
Ins Owners10.1%
Ins Owner Change0.7%
Market Cap1.72B
Revenue(TTM)9.14B
Net Income(TTM)-386000000
Analysts46.67
Price Target4.5 (-4.66%)
Short Float %18.74%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.3%
Min EPS beat(2)5.75%
Max EPS beat(2)52.85%
EPS beat(4)4
Avg EPS beat(4)32.59%
Min EPS beat(4)5.75%
Max EPS beat(4)52.85%
EPS beat(8)7
Avg EPS beat(8)37.53%
EPS beat(12)9
Avg EPS beat(12)25.42%
EPS beat(16)12
Avg EPS beat(16)2.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)1.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.76%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)1.12%
Revenue beat(8)1
Avg Revenue beat(8)-1.12%
Revenue beat(12)1
Avg Revenue beat(12)-1.31%
Revenue beat(16)2
Avg Revenue beat(16)-1.35%
PT rev (1m)0%
PT rev (3m)0.56%
EPS NQ rev (1m)5.31%
EPS NQ rev (3m)6.72%
EPS NY rev (1m)2.12%
EPS NY rev (3m)8.72%
Revenue NQ rev (1m)0.72%
Revenue NQ rev (3m)1.94%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 0.86
EV/EBITDA 11.56
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-3.42
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS25.13
BVpS6.62
TBVpS5.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.28%
ROE -16.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69%
FCFM N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 3.21
Debt/FCF N/A
Debt/EBITDA 14.49
Cap/Depr 178.27%
Cap/Sales 13.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.84
Altman-Z 0.63
F-Score4
WACC5.39%
ROIC/WACCN/A
Cap/Depr(3y)199.72%
Cap/Depr(5y)186.25%
Cap/Sales(3y)13.36%
Cap/Sales(5y)16.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-125.95%
EPS Next 2Y-16.26%
EPS Next 3Y19.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.9%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.97%
Revenue Next Year-2.19%
Revenue Next 2Y2.2%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y46.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year263.73%
EBIT Next 3Y89.31%
EBIT Next 5YN/A
FCF growth 1Y-317.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-106.33%
OCF growth 3Y-55.57%
OCF growth 5Y-36.98%

JETBLUE AIRWAYS CORP / JBLU FAQ

What is the fundamental rating for JBLU stock?

ChartMill assigns a fundamental rating of 2 / 10 to JBLU.


What is the valuation status for JBLU stock?

ChartMill assigns a valuation rating of 0 / 10 to JETBLUE AIRWAYS CORP (JBLU). This can be considered as Overvalued.


How profitable is JETBLUE AIRWAYS CORP (JBLU) stock?

JETBLUE AIRWAYS CORP (JBLU) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for JBLU stock?

The Earnings per Share (EPS) of JETBLUE AIRWAYS CORP (JBLU) is expected to decline by -125.95% in the next year.